本文由小咖机器人翻译整理

期刊来源：Lancet

原文链接：https://doi.org/10.1016/S0140-6736(23)01429-0

摘要内容如下：

虽然多巴胺替代疗法仍然是帕金森病治疗的核心组成部分，但运动波动和运动障碍的发作可能需要多学科团队的一系列医疗和手术方法，并且多巴胺替代疗法的重要新方法正在出现。更具挑战性的、广泛的非运动症状也会对帕金森病患者的生活质量产生重大影响，需要利用循证知识进行仔细的多学科管理，并根据患者的个体需求制定适当的策略。迫切需要疾病改善疗法来预防最具致残性的难治性症状的发展，包括步态和平衡困难、认知障碍和痴呆以及言语和吞咽障碍。在本系列的第三篇论文中，我们提出了支持帕金森病最佳治疗的最新证据，并描述了证据基础不足的治疗选择的许多方面的专家方法。

英文原文如下：

Abstracts

Although dopamine replacement therapy remains a core component of Parkinson's disease treatment, the onset of motor fluctuations and dyskinetic movements might require a range of medical and surgical approaches from a multidisciplinary team, and important new approaches in the delivery of dopamine replacement are becoming available. The more challenging, wide range of non-motor symptoms can also have a major impact on the quality of life of a patient with Parkinson's disease, and requires careful multidisciplinary management using evidence-based knowledge, as well as appropriately tailored strategies according to the individual patient's needs. Disease-modifying therapies are urgently needed to prevent the development of the most disabling refractory symptoms, including gait and balance difficulties, cognitive impairment and dementia, and speech and swallowing impairments. In the third paper in this Series, we present the latest evidence supporting the optimal treatment of Parkinson's disease, and describe an expert approach to many aspects of treatment choice where an evidence base is insufficient.

-----------分割线---------

点击链接：https://www.mediecogroup.com/community/user/vip/categories/ ，成为医咖会员，获取12项专属权益。

现在购买可享受最大优惠（买一年送三个月，买两年送一年），2024年2月10日起将不再享有该优惠。